• Hello Visitor!
  • Log In or Register
  • About BIO
  • BIO International Convention
  • Blogs
  • members.bio.org
  • Media
  • Contact
BIO
  • About BIO
  • BIO International Convention
  • Blogs
  • members.bio.org
  • Media
  • Contact
  • Home
  • Advocacy
    • What is Biotechnology?
    • Federal Government Relations
    • About BIO
      • Board of Directors & Executive Committees
      • Senior Staff
    • State Government Relations
    • International Advocacy
    • Letters, Testimony & Comments
    • Alliance Development
    • Amicus Briefs
  • Areas of Work
    • Health Care
      • Biopharmaceutical Manufacturing and Distribution
      • Biosimilars
      • Drug Discovery and Development
      • Food and Drug Administration Review
      • Personalized Medicine
      • Prescription Drug User Fee Act
      • Reimbursement and Health Policy
      • Vaccines and Biodefense
    • Emerging Companies
      • Capital Formation
      • Funding
      • International Market Access
      • Technology Transfer
      • Therapeutic Discovery Project Credit
    • Intellectual Property
      • Biodiversity and Bioprospecting
      • Gene Patenting
      • Patent Law Harmonization
      • Intellectual Property and Trade
      • Technology Transfer
      • Patent Reform
    • Industrial & Environmental
      • Advanced Biofuels
      • Algae
      • Climate Change
      • Marine Biotechnology
      • Renewable Chemicals & Biobased Materials
      • Renewable Specialty Chemicals
      • Synthetic Biology
    • Food & Agriculture
      • Animal Biotechnology
      • Plant Biotechnology
      • Sustainable Agriculture
    • Public Policy
      • Regulatory Affairs
      • State & Local Issues
      • State Biotech Policy
      • Stewardship
    • Bioethics
    • International Trade
    • Small Business Early Stage Investment
  • Conferences & Events
    • BIO International Convention
    • Intellectual Property
      • BIO IP Counsels Committee Conference
    • Industrial & Environmental
      • World Congress on Industrial Biotechnology
      • Pacific Rim Summit on Industrial Biotechnology & Bioenergy
    • Business Development
      • BIO Asia International Conference
      • BIO Convention in China
    • Food & Agriculture
      • BIO Livestock Summit
    • Partnered Events
      • BioEquity Europe
      • BIO-Europe
      • BIO-Europe Spring
    • Investor Events
      • BIO CEO & Investor Conference
      • BIO Investor Forum
    • Specialized Events
      • BIO Legislative Day Fly-In
      • BioSafe Annual General Membership Meeting
    • Executive Training Programs
      • Advanced Business Development Course
      • Business Development Basics
  • Industry Intelligence & Analysis
    • Backgrounders
    • Battelle Report
    • Agricultural Product Database
    • BIOtech NOW
    • Industry Best Practices
    • Publications
  • Member Services
    • Cost Savings / Discounts
    • Membership/Join BIO
    • Business Solutions
    • Membership Dues Schedule
    • Membership Benefits
    • Online Membership Application
    • Suggestion Box
    • Member Directory
  • Resources
    • BIO Grassroots Handbook
    • Food and Drug Administration
    • Council of State Bioscience Associations
    • Government Funding and Grants
    • IP Counsels Committee
    • Health Care Reform
    • Patent and Trademark Office
    • Securities and Exchange Commission
    • The Sarbanes-Oxley (SOX) Act
Home
swhitaker's picture
Scott Whitaker
Chief Operating Officer

Download a hi-res photo

Scott Whitaker is the Chief Operating Officer of the Biotechnology Industry Organization (BIO). He joined BIO in February 2005 as COO and manages all aspects of BIO’s day-to-day operations. Prior to joining BIO, Scott served as Chief of Staff of the 8 of Health & Human Services (HHS), a cabinet agency with 67,000 employees and a budget of $550 billion. As HHS Chief of Staff, Scott managed the day-to-day operations of the 8 and led the 8’s activities on all major policy and management issues and initiatives. In addition, he served as the top liaison to the White House on policy, management and political matters. Prior to becoming Chief of Staff, Scott was nominated by the President and confirmed by the U.S. Senate to serve as Assistant Secretary for Legislation, 8 of Health and Human Services. In that capacity, Scott led the legislative operations of the 8 and its agencies. During his time as Assistant Secretary, Scott managed the passage of a significant number of legislative victories for the Administration, including the Medicare Modernization Act, the Bioterrorism Preparedness Act of 2002, the Medical Device User Fee and Modernization Act of 2002, and the Project BioShield Act of 2004. Before joining HHS, Scott served on the staff of Senate Assistant Majority Leader Don Nickles. He joined Sen. Nickles in 1991. In 1997, Nickles appointed Scott as policy advisor for the Office of the Assistant Majority Leader, where he served for the next four years. Scott holds a Master's degree from Johns Hopkins University and a Bachelor's degree from Palm Beach Atlantic University. He and his wife, Michelle, have three children.

  • Join Us:

  •  
  •  
  •  
  •  
Receive our newsletter from BIOtechNOW

Subscribe to Our Newsletter

Most Viewed Articles

  • What is Biotechnology?
  • About BIO
  • Board of Directors & Executive Committees
  • BIO Members & Web Site Links
  • Join BIO

BIO Convention

BBS

  • About BIO
  • Careers
  • Privacy Policy
  • Terms of Use
  • Advertising
  • Conferences by Date
Get the main site RSS feed
Why Join BIO?
SUPPORT
BIO Business Solutions
Find out how over 2,500 companies save money with our program.
Membership FAQs
Is my organization eligible for membership? Where can I find an application to join BIO?
State Bioscience Industry Development
INDUSTRY SPOTLIGHT
Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life
Biotechnology is all around us and is already a big part of our lives.
Frequently Asked Questions: Biotech Crops and Labeling
As the use of agricultural biotechnology increases, people need information about food production that is truthful.
What is Biotechnology?
KEY INITIATIVES
Unleashing the Promise of Biotechnology
BIO released a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation.
Bioethics
Testimony on the ethical performance of international clinical trials.
Become a Sponsor
2013 BIO International Convention
ADDITIONAL RESOURCES
Industry Calendar
Learn about industry events in your area.
Submit an Event
Add your conference or event to our Industry Calendar and increase your attendance.
The BIO Grassroots Network
TOPICS OF INTEREST
Biomass & Biofuels
BIO provided Congress with information on the impact of USDA bioenergy programs.
Food & Drug Administration
A new white papershows that the FDA can help expand the economy.